Ovarian cancer remains an important cause of female cancer-related deaths, with approximately 22,440 new cases and about 14,080 deaths predicted for 2017. Consistent with the objective of this proposal, there is an urgent need to identify better targets for therapy against advanced and drug-resistant high-grade serous ovarian cancer (HGSOC), the most malignant and lethal of the gynecological cancers. One such possibility is c-MYC, an oncogene highly abundant in most cancers, including HGSOC. Previous studies by our research team using ?The Cancer Genome Atlas? (TCGA) data portal showed that recurrence of HGSOC occurred faster for patients with higher c-MYC expression. In addition, small-interference RNA (siRNA)-mediated c-MYC silencing decreased cell proliferation and reduced tumor growth in an ovarian cancer mouse model. Together, these results suggest that c-MYC could be a clinically relevant target for HGSOC patients. Although the molecular mechanisms of c-MYC overexpression have been extensively studied in different types of cancer, the mechanism leading to c-MYC up-regulation in HGSOC have not been addressed. Preliminary results from our research team indicate that c-MYC could be regulated post-transcriptionally by microRNAs in HGSOC. MicroRNAs (miRNAs) are small non-coding RNAs that can potentially bind to thousands of different messenger RNAs and inhibit protein synthesis. By using bioinformatics and molecular studies we identified several miRNAs that potentially regulate c-MYC expression in ovarian cancer cells. Most important, transient transfection of oligonucleotide miRNA mimics for those miRNAs showed that miR-98, miR-106a and miR-18a significantly decreased the c-MYC protein levels, and reduced the cell proliferation of ovarian cancer cells. Together, our data provide insight into novel mechanisms of c-MYC regulation in HGSOC. Our overall hypothesis is that miR-98, miR-106a and miR-18a post-transcriptionally regulate c-MYC expression in HGSOC. In addition, we will test the hypothesis that c-MYC regulates key genes associated with cell survival and with the cisplatin resistance of HGSOC cells. This hypothesis will be addressed by pursuing the following Specific Aims: (1) identify the microRNAs post-transcriptionally regulating c-MYC expression in HGSOC cells; (2) investigate the biological consequences and therapeutic effects of siRNA-mediated c-MYC silencing in combination with miR-98, miR-106a or miR-18a mimics, in HGSOC; and (3) elucidate the c-MYC downstream effectors in ovarian cancer cells. Our contribution to the field of molecular mechanisms of drug resistance will be a detailed elucidation of the Upstream Regulation and Downstream Effectors of c-MYC in HGSOC. In response to one of the main missions of the ?Center for Collaborative Research in Health Disparities? (RCMI), this proposal will improve the participation of researchers in minority institutions in basic and translational cancer research and will result in the training of local graduate and undergraduate students in cutting-edge technology and novel concepts in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD007600-32
Application #
9570675
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
32
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Puerto Rico Med Sciences
Department
Type
DUNS #
948108063
City
San Juan
State
PR
Country
United States
Zip Code
Colón, Jennifer M; González, Pablo A; Cajigas, Ámbar et al. (2018) Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats. Exp Neurol 299:109-121
Colón-Cruz, Luis; Kristofco, Lauren; Crooke-Rosado, Jonathan et al. (2018) Alterations of larval photo-dependent swimming responses (PDR): New endpoints for rapid and diagnostic screening of aquatic contamination. Ecotoxicol Environ Saf 147:670-680
Jezzini, Sami H; Merced, Amelia; Blagburn, Jonathan M (2018) Shaking-B misexpression increases the formation of gap junctions but not chemical synapses between auditory sensory neurons and the giant fiber of Drosophila melanogaster. PLoS One 13:e0198710
Crespo, Maria J; Roman, Marie; Matias, Jonathan et al. (2018) Synergistic Effects of Dantrolene and Nimodipine on the Phenylephrine-Induced Contraction and ACh-Induced Relaxation in Aortic Rings from Diabetic Rats. Int J Endocrinol 2018:9790303
Hernandez-Suarez, Dagmar F; Botton, Mariana R; Scott, Stuart A et al. (2018) Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population. Pharmgenomics Pers Med 11:95-106
Martínez-Rivera, Freddyson J; Barreto-Estrada, Jennifer L (2018) Reply to: Does High-Frequency Deep Brain Stimulation in Dorsal Regions of the Ventral Striatum Impair Extinction of Morphine-Induced Place Preference? Biol Psychiatry 83:e21
Hernandez-Suarez, Dagmar F; Núñez-Medina, Hector; Scott, Stuart A et al. (2018) Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy. Drug Metab Pers Ther 33:49-55
Hedges, Jerris R; Soliman, Karam F A; D'Amour, Gene et al. (2018) Academic Response to Storm-Related Natural Disasters-Lessons Learned. Int J Environ Res Public Health 15:
Rosario-Rodríguez, Lester J; Colón, Krystal; Borges-Vélez, Gabriel et al. (2018) Dimethyl Fumarate Prevents HIV-Induced Lysosomal Dysfunction and Cathepsin B Release from Macrophages. J Neuroimmune Pharmacol :
Sierra-Mercado, Demetrio; Lázaro-Muñoz, Gabriel (2018) Enhance Diversity Among Researchers to Promote Participant Trust in Precision Medicine Research. Am J Bioeth 18:44-46

Showing the most recent 10 out of 48 publications